Delivery Order SPE2DB22D3401-SPE2DB25FT1QZ

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOMID 50 MG TABLET UD 30S, a medication, with a ceiling value of $4,116.48. The contract is a firm fixed-price, Indefinite Delivery Contract with a completion date of January 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a ceiling value of $2,611.15. The contract is a firm fixed-price delivery order, with a period of performance through July 2024. This contract is not set aside for any specific business size or socioeconomic status. AmerisourceBergen Drug...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,811.20 for the supply of CLOMID 50 MG TABLET UD 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of October 18, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,611.41, is for the supply of 4566795177 CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of December 27, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of CLOMID 50 MG TABLET UD 30S. The award, valued at $9,535.49, is a firm fixed price contract with a period of performance through July 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CLOMID 50 MG TABLET UD 30S, a prescription medication. The award, valued at $1,122.45, was made on August 27, 2024, with a completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CLOMID 50 MG TABLET UD 30S. The contract has a potential value of $1,213.86 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, particularly the...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,306.18, is to supply CLOMID 50 MG TABLET UD 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the supply of CLOMID 50 MG TABLET UD 30S, with a potential value of $2,638.86 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,698.50, is for the delivery of CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of January 13, 2025 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and there are no major...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT1QZ
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product. The contract has a ceiling value of $2,263.86 and runs from January 15, 2025 to January 16, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/21/25, 3:49 AM